EmbryoScope approved for sales in China

2018-02-01 - 11:00

Vitrolife AB (publ) has today received market approval for the time-lapse incubator EmbryoScope in China and thereby becomes the first company to market an approved time-lapse incubator in the world´s largest IVF market.

EmbryoScope is a time-lapse system with an integrated incubator with a capacity for six patients. Vitrolife is the market leader of time-lapse systems for use in assisted reproduction for undisturbed culture and improved selection of embryos. “There is a great interest for time-lapse in China and we are delighted to now being able to offer EmbryoScope to the clinics in China”, says Thomas Axelsson, CEO of Vitrolife.

February 1, 2018
Thomas Axelsson, CEO

Queries should be addressed to:
Thomas Axelsson, CEO, tel 46 31 721 80 01
Mikael Engblom, CFO, tel 46 31 721 80 14

This information is information that Vitrolife AB is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out above, at 11.00 am CET on February 1, 2018.

This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.